Patents by Inventor Anne Minnich

Anne Minnich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN
    Publication number: 20210221882
    Abstract: Uses of a dual V region antibody-like protein or a fragment of a dual V region antibody-like region.
    Type: Application
    Filed: April 7, 2021
    Publication date: July 22, 2021
    Inventors: Florent C. BENDER, Danxi LI, Anne MINNICH, Amirtha NAADIMUTHU, Ercole RAO, Brian N. SWANSON, Lei TANG, Haixin YU, Otmane BOUSSIF, Sophie CARAYON
  • Uses of a dual V region antibody-like protein
    Patent number: 11008389
    Abstract: Uses of a dual V region antibody-like protein or a fragment of a dual V region antibody-like region.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: May 18, 2021
    Assignee: SANOFI
    Inventors: Florent C. Bender, Danxi Li, Anne Minnich, Amirtha Naadimuthu, Ercole Rao, Brian N. Swanson, Lei Tang, Haixin Yu, Otmane Boussif, Sophie Carayon
  • USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN
    Publication number: 20170029498
    Abstract: Uses of a dual V region antibody-like protein or a fragment of a dual V region antibody-like region.
    Type: Application
    Filed: July 8, 2016
    Publication date: February 2, 2017
    Inventors: Florent BENDER, Danxi LI, Anne MINNICH, Amirtha NAADIMUTHU, Ercole RAO, Brian N. SWANSON, Lei TANG, Haixin YU
  • USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN
    Publication number: 20130344074
    Abstract: Uses of a dual V region antibody-like protein or a fragment of a dual V region antibody-like region.
    Type: Application
    Filed: March 15, 2012
    Publication date: December 26, 2013
    Applicant: SANOFI
    Inventors: Florent Bender, Danxi Li, Anne Minnich, Amirtha Naadimuthu, Ercole Rao, Brian N. Swanson, Lei Tang, Haixin Yu
  • TREATMENT OF DERMATOLOGICAL ALLERGIC CONDITIONS
    Publication number: 20120309790
    Abstract: A treatment for a dermatological allergic condition is disclosed, using a compound of Formula I:
    Type: Application
    Filed: August 20, 2012
    Publication date: December 6, 2012
    Applicant: SANOFI
    Inventors: Yong Mi CHOI-SLEDESKI, Neil FITCH, Anne MINNICH
  • TREATMENT FOR INFLAMMATORY BOWEL DISEASE
    Publication number: 20120238603
    Abstract: The present invention relates to a method for the treatment of an inflammatory bowel disease by the administration of the compound [4-(5-aminomethyl-2-fluorophenyl)piperidine-1-yl][7-fluoro-1-(2-methoxyethyl)-4-trifluoromethoxy-1H-indol-3-yl]methanone, which may be represented as Formula I: or a corresponding N-oxide, prodrug, pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: June 5, 2012
    Publication date: September 20, 2012
    Applicant: SANOFI
    Inventors: Anne MINNICH, Eszter BEKASI, Yong Mi CHOI-SLEDESKI
  • OXYDECAHYDRONAPHTHALENE MODULATORS OF HM74
    Publication number: 20080045586
    Abstract: Host cells expressing HM74 were used to obtain oxydecalin-like molecules with agonist activity having the following structure:
    Type: Application
    Filed: August 30, 2007
    Publication date: February 21, 2008
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Anne MINNICH, Theresa KUNTZWEILER, Haifeng EISHINGDRELO, Michael ANGELASTRO, Stephan HENKE
  • Oxydecahydronaphthalene modulators of HM74
    Patent number: 7264937
    Abstract: Host cells expressing HM74 were used to obtain oxydecalin-like molecules with agonist activity having the following structure:
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: September 4, 2007
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Anne Minnich, Theresa Kuntzweiler, Haifeng Eishingdrelo, Michael Angelastro, Stephan Henke
  • USE OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONISTS FOR THE TREATMENT OF MS AND OTHER DEMYELINATING DISEASES
    Publication number: 20070149580
    Abstract: A method for treating demyelinating diseases in a patient in need thereof by treatment with an effective amount of a PPAR delta agonist is disclosed. Demyelinating diseases that may be effectively treated by this method include but are not limited to multiple sclerosis, Charcot-Marie-Tooth disease, Pelizaeus-Merzbacher disease, encephalomyelitis, neuromyelitis optica, adrenoleukodystrophy, Guillian-Barre syndrome and disorders in which myelin forming glial cells are damaged including spinal cord injuries, neuropathies and nerve injury.
    Type: Application
    Filed: September 26, 2006
    Publication date: June 28, 2007
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Karen CHANDROSS, Jean MERRILL, Anne MINNICH, Lan LEE, Olga KHORKOVA, Yun LIU
  • Furosemide modulators of HM74
    Patent number: 7232811
    Abstract: Host cells expressing HM74 were used to obtain furosemide-like molecules with agonist activity having the following structure formula:
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: June 19, 2007
    Assignees: Aventis Pharmaceuticals Inc., Sanofi-Aventis Deutschland GmbH
    Inventors: Anne Minnich, Theresa Kuntzweiler, Haifeng Eishingdrelo, Michael Angelastro, Hans-Jochen Lang
  • Therapeutic uses of tri-aryl acid derivatives
    Patent number: 7005440
    Abstract: The use of triaryl acid derivatives of formula (I) and their pharmaceutical compositions as PPAR ligand receptor binders. The PPAR ligand receptor binders of this invention are useful as agonists or antagonists of the PPAR receptor.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 28, 2006
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Zaid Jayyosi, Gerard M. McGeehan, Michael F. Kelley, Richard F. Labaudiniere, Litao Zhang, Robert D. Groneberg, Daniel G. McGarry, Thomas J. Caulfield, Anne Minnich, Mark Bobko, Robert Morris
  • Oxydecahydronaphthalene modulators of HM74
    Publication number: 20050187263
    Abstract: Host cells expressing HM74 were used to obtain oxydecalin-like molecules with agonist activity having the following structure:
    Type: Application
    Filed: February 14, 2005
    Publication date: August 25, 2005
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Anne Minnich, Theresa Kuntzweiler, Haifeng Eishingdrelo, Michael Angelastro, Stephan Henke
  • Furosemide modulators of HM74
    Publication number: 20050187280
    Abstract: Host cells expressing HM74 were used to obtain furosemide-like molecules with agonist activity having the following structure formula:
    Type: Application
    Filed: February 14, 2005
    Publication date: August 25, 2005
    Applicants: Aventis Pharmaceuticals Inc., Aventis Pharma Deutschland GmbH
    Inventors: Anne Minnich, Theresa Kuntzweiler, Haifeng Eishingdrelo, Michael Angelastro, Hans-Jochen Lang
  • Therapeutic uses of PPAR mediators
    Publication number: 20030220373
    Abstract: Use of PPAR mediators, and their pharmaceutical compositions, as ATP binding cassette transporter 1 (ABC-1) expression modulators, wherein the PPAR ligand receptor agonists of this invention are useful as inducers of ABC-1 expression.
    Type: Application
    Filed: September 9, 2002
    Publication date: November 27, 2003
    Inventors: Michael Jaye, Nicolas Duverger, George Searfoss, Anne Minnich
  • Therapeutic uses of di-aryl acid derivatives
    Patent number: 6635655
    Abstract: The use of diaryl acid derivatives of formula (I) or pharmaceutically acceptable salts, N-oxides, hydrates or solvates thereof, wherein the variables shown are defined in the disclosure, and their pharmaceutical compositions as PPAR ligand receptor binders. The PPAR ligand receptor binders of this invention are useful as agonists or antagonists of the PPAR receptor.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: October 21, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Zaid Jayyosi, Gerard M. McGeehan, Michael F. Kelley, Richard F. Labaudiniere, Litao Zhang, Robert D. Groneberg, Daniel G. McGarry, Thomas J. Caulfield, Anne Minnich, Mark Bobko
  • Novel G protein-coupled receptor, GAVE3
    Publication number: 20030059869
    Abstract: Novel GAVE3 polypeptides, proteins and nucleic acid molecules are provided. In addition to isolated, full-length GAVE3 proteins, isolated GAVE3 fusion proteins, antigenic peptides and anti-GAVE3 antibodies are taught.
    Type: Application
    Filed: June 22, 2001
    Publication date: March 27, 2003
    Inventors: Tai-He Xia, Donghui Ni, Haifeng Eishingdrelo, Ali Ardati, Anne Minnich, Ray Jupp
  • Therapeutic uses of di-aryl acid derivatives
    Patent number: RE40558
    Abstract: The use of diaryl acid derivatives of formula (I) or pharmaceutically acceptable salts, N-oxides, hydrates or solvates thereof, wherein the variables shown are defined in the disclosure, and their pharmaceutical compositions as PPAR ligand receptor binders. The PPAR ligand receptor binders of this invention are useful as agonists or antagonists of the PPAR receptor.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: October 28, 2008
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Zaid Jayyosi, Gerard M. McGeehan, Michael F. Kelley, Richard F. Labaudiniere, Litao Zhang, Robert D. Groneberg, Daniel G. McGarry, Thomas J. Caulfield, Anne Minnich, Mark Bobko